ArticleImmunity, inflammation and disease2021
Pediatric asthma control during the COVID-19 pandemic.
Article in Immunity, inflammation and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pediatric asthma control during the COVID-19 pandemic: A systematic review and meta-analysis.Pediatric pulmonology · 2022Pooled it
- [Efficacy and safety of dust mite subcutaneous immunotherapy in children with allergic asthma： a prospective randomized controlled study].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024Trial
- Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data.Health economics · 2026Article
- Impact of the COVID-19 Pandemic on Lung Function and Treatment Decisions in Children with Asthma: A Retrospective Study.Journal of clinical medicine · 2025Article
- The COVID-19 pandemic and asthma management: a family caregiver perspective.The Journal of asthma : official journal of the Association for the Care of Asthma · 2025Article
- Preschool Asthma Children: Navigating COVID-19's Impact on Treatment Adherence.Turkish archives of pediatrics · 2025Article
- Pediatric asthma comorbidities: Global impact and unmet needs.The World Allergy Organization journal · 2024Review
- Examining Coping Strategies and Their Relation with Anxiety: Implications for Children Diagnosed with Cancer or Type 1 Diabetes and Their Caregivers.International journal of environmental research and public health · 2024Article
- Impact of the COVID-19 on asthma control among children: A systematic review.Journal of public health research · 2023Review
- Reduced asthma morbidity during COVID-19 in minority children: is medication adherence a reason?The Journal of asthma : official journal of the Association for the Care of Asthma · 2023Article
- Healthcare utilization in Canadian children and young adults with asthma during the COVID-19 pandemic.PloS one · 2023Article
- Youth and caregiver asthma functioning and quality of life throughout the COVID-19 pandemic.Frontiers in allergy · 2023Article
- Management of patients with allergic diseases in the era of COVID-19.Clinical and experimental pediatrics · 2022Article
- Age-dependent rebound in asthma exacerbations after COVID-19 lockdown.The journal of allergy and clinical immunology. Global · 2022Article
- Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022Article
- The impact of COVID-19 lockdown on children with recurrent wheezing and asthma in Spain.Journal of paediatrics and child health · 2022Article
- Effect of the COVID-19 Lockdown on Asthma Biological Rhythms.Journal of biological rhythms · 2022Article
- Systemic antibiotics and asthma medicines dispensed to 0-12 year olds significantly decreased during the COVID-19 pandemic in 2020.Acta paediatrica (Oslo, Norway : 1992) · 2022Article
- Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.British journal of haematology · 2021Article
- Pediatric asthma control during the COVID-19 pandemic.Immunity, inflammation and disease · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe lockdown imposed by the COVID-19 pandemic resulted in a completely different style of life with possible effects on the attitude toward their disease in patients with chronic lung disease, such as asthma. The aim of our study was to investigate in asthmatic children the level of asthma control and the maintenance therapy used during the lockdown.
methodsAmong asthmatic children attending our clinic, we identified those who had been prescribed the same therapy in March-April 2019 and March-April 2020. The level of asthma control (GINA-score) and the maintenance therapy used during the lockdown (March-April 2020) were compared with those of March-April 2019. We separately analyzed a small group of children with severe asthma treated with Omalizumab during the lockdown.
resultsWe enrolled 92 asthmatic children (67 males). Compared to 2019, in 2020 a higher proportion of children modified their maintenance therapy (38% vs. 15.2%, p < .001), with a significant increase in both the proportion of children who increased (p = .033) and in that of children who decreased their therapy (p = .026). The level of control resulted as significantly higher in 2020 (March p = .023; April p = .007). Also, the 13 children treated with Omalizumab showed a good level of control in 2020.
conclusionsIn asthmatic children, the COVID-19 pandemic lockdown had a significant impact on their asthma control and on their attitude toward maintenance therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.